| scholarly article | Q13442814 |
| P2093 | author name string | Sun Mi Kim | |
| Gyeong-Won Lee | |||
| Heon Han | |||
| Rock Bum Kim | |||
| Seok Jin Nam | |||
| Yeon Hee Park | |||
| Boo-Kyung Han | |||
| Eun Sook Ko | |||
| P2860 | cites work | Comparison of hormonal receptor and HER2 status between ultrasound-guided 14-gauge core needle biopsy and surgery in breast cancer patients | Q30434356 |
| Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer | Q34601123 | ||
| Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657. | Q36212421 | ||
| Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy | Q36431261 | ||
| Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma | Q36613700 | ||
| Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference | Q37079615 | ||
| Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease | Q37079625 | ||
| Update on neoadjuvant/preoperative therapy of breast cancer: experiences from the German Breast Group | Q38069421 | ||
| Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation | Q38099631 | ||
| Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis | Q38188183 | ||
| Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. | Q40675977 | ||
| Breast cancer molecular subtypes respond differently to preoperative chemotherapy | Q42482998 | ||
| The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes | Q42511189 | ||
| Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. | Q46765380 | ||
| Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer | Q46771645 | ||
| Response-guided neoadjuvant chemotherapy for breast cancer. | Q52882601 | ||
| Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. | Q53247398 | ||
| Analysis of factors that influence the accuracy of magnetic resonance imaging for predicting response after neoadjuvant chemotherapy in locally advanced breast cancer. | Q54446011 | ||
| Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. | Q54516956 | ||
| The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer. | Q55052653 | ||
| HER2 and Response to Paclitaxel in Node-Positive Breast Cancer | Q57578418 | ||
| Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging | Q71117011 | ||
| MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation | Q73947917 | ||
| Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI | Q74207464 | ||
| Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy | Q74445914 | ||
| Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system | Q80358653 | ||
| Patterns of local and distant disease relapse in patients with breast cancer treated with primary chemotherapy: do patients with a complete pathological response differ from those with residual tumour in the breast? | Q81268146 | ||
| Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials | Q82271267 | ||
| Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27 | Q83137320 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| Breast MRI | Q4959770 | ||
| P1104 | number of pages | 10 | |
| P304 | page(s) | 986-995 | |
| P577 | publication date | 2015-08-21 | |
| P1433 | published in | Korean journal of radiology : official journal of the Korean Radiological Society | Q26842124 |
| P1476 | title | Prognostic Significance of a Complete Response on Breast MRI in Patients Who Received Neoadjuvant Chemotherapy According to the Molecular Subtype | |
| P478 | volume | 16 |
| Q33829617 | Accuracy of axillary ultrasound after different neoadjuvant chemotherapy cycles in breast cancer patients |
| Q55379016 | Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer. |
| Q37589530 | Estimation of T2* Relaxation Time of Breast Cancer: Correlation with Clinical, Imaging and Pathological Features |
| Q90629017 | Higher underestimation of tumour size post-neoadjuvant chemotherapy with breast magnetic resonance imaging (MRI)-A concordance comparison cohort analysis |
| Q47389056 | MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy. |
| Q89663290 | Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis |
| Q61804885 | Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR) |
| Q42702576 | Selection and Reporting of Statistical Methods to Assess Reliability of a Diagnostic Test: Conformity to Recommended Methods in a Peer-Reviewed Journal |
Search more.